论文部分内容阅读
目的:评价复方阿嗪米特肠溶片对消化不良患者的疗效及安全性。方法:选取93例消化不良患者,根据引发消化不良病症的不同病因,给予复方阿嗪米特肠溶片治疗;观察治疗前后患者病症的改善情况。结果:治疗后,患者消化不良的总有效率达84.95%;治疗后患者食欲不振、恶心呕吐、便秘、胃部具灼烧感(胃酸过多)、腹痛、腹胀和嗳气症状积分值优于治疗前(P<0.05);治疗过程中未出现严重药物不良反应。结论:复方阿嗪米特肠溶片对功能性消化不良患者的疗效较显著,能有效缓解其临床症状,且安全性较高。
Objective: To evaluate the efficacy and safety of compound azintamide enteric-coated tablets in patients with dyspepsia. Methods: Ninety-three patients with dyspepsia were selected according to the different etiopathogenisis caused by dyspepsia. The patients were treated with the compound azintamide enteric-coated tablets. The improvement of the patients’ symptoms was observed before and after treatment. Results: After treatment, the total effective rate of patients with dyspepsia was 84.95%. After treatment, patients had poor appetite, nausea and vomiting, constipation, burning sensation in the stomach (hyperacidity), abdominal pain, abdominal distention and belching symptom scores (P <0.05). No serious adverse drug reactions occurred during the course of treatment. Conclusion: The compound azintomide enteric-coated tablets is effective in patients with functional dyspepsia and can effectively relieve the clinical symptoms and is safe.